Article
Inhibition of USP10 induces degradation of oncogenic FLT3.
Nature chemical biology - 1 Dec 2017
Weisberg Ellen L, Schauer Nathan J, Yang Jing, Lamberto Ilaria, Doherty Laura, Bhatt Shruti, Nonami Atsushi, Meng Chengcheng, Letai Anthony, Wright Renee, Tiv Hong, Gokhale Prafulla C, Ritorto Maria Stella, De Cesare Virginia, Trost Matthias, Christodoulou Alexandra, Christie Amanda, Weinstock David M, Adamia Sophia, Stone Richard, Chauhan Dharminder, Anderson Kenneth C, Seo Hyuk-Soo, Dhe-Paganon Sirano, Sattler Martin, Gray Nathanael S, Griffin James D, Buhrlage Sara J
Abstract excerpt
Oncogenic forms of the kinase FLT3 are important therapeutic targets in acute myeloid leukemia (AML); however, clinical responses to small-molecule kinase inhibitors are short-lived as a result of the rapid emergence of resistance due to point mutations or compensatory increases in FLT3 expression. We sought to develop a complementary pharmacological approach whereby proteasome-mediated FLT3 degradation could be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
